Guagnano; Vito

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guagnano; Vito.The latest application filed is for "fgfr inhibitor for use in the treatment of hypophosphatemic disorders".

Company Profile

0.47.70

Guagnano; Vito - Basel CH
GUAGNANO; Vito - Lecce IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fgfr Inhibitor For Use In The Treatment Of Hypophosphatemic Disorders App 20210308132 - Kneissel; Michaela ; et al.	2021-10-07
Biaryl Derivatives As Yap/taz-tead Protein-protein Interaction Inhibitors App 20210299100 - BORDAS; Vincent ; et al.	2021-09-30
FGFR inhibitor for use in the treatment of hypophosphatemic disorders Grant 10,028,955 - Kneissel , et al. July 24, 2	2018-07-24
Imidazopyrrolidine derivatives and their use in the treatment of disease Grant 9,890,166 - Blank , et al. February 13, 2	2018-02-13
Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease Grant 9,714,249 - Blank , et al. July 25, 2	2017-07-25
Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease Grant 9,624,247 - Blank , et al. April 18, 2	2017-04-18
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction Grant 9,556,180 - Furet , et al. January 31, 2	2017-01-31
Pyrrolopyrrolone derivatives and their use as BET inhibitors Grant 9,550,796 - Rueger , et al. January 24, 2	2017-01-24
Fgfr Inhibitor For Use In The Treatment Of Hypophosphatemic Disorders App 20170007606 - Kneissel; Michaela ; et al.	2017-01-12
Pyrrolopyrrolone Derivatives And Their Use As Bet Inhibitors App 20160280719 - BLANK; Jutta ; et al.	2016-09-29
Substituted purinone compounds Grant 9,403,827 - Furet , et al. August 2, 2	2016-08-02
Pyrrolopyrrolidinone compounds Grant 9,365,576 - Cotesta , et al. June 14, 2	2016-06-14
Imidazopyrrolidine Derivatives And Their Use In The Treatment Of Disease App 20160108047 - BLANK; Jutta ; et al.	2016-04-21
Pyrazolo-pyrrolidin-4-one Derivatives As Bet Inhibitors And Their Use In The Treatment Of Disease App 20160102107 - BLANK; Jutta ; et al.	2016-04-14
N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-urea App 20160102062 - Aichholz; Reiner ; et al.	2016-04-14
Pyrazolopyrrolidine Derivatives And Their Use In The Treatment Of Disease App 20160095843 - BLANK; Jutta ; et al.	2016-04-07
Pyrazolo-pyrrolidin-4-one Derivatives And Their Use In The Treatment Of Disease App 20160096843 - BLANK; Jutta ; et al.	2016-04-07
Pyrazolo[3,4-d]pyrimidinone Compounds As Inhibitors Of The P53/mdm2 Interaction App 20150353563 - FURET; Pascal ; et al.	2015-12-10
Substituted Purinone Compounds App 20150353551 - FURET; Pascal ; et al.	2015-12-10
Methods Of Monitoring The Modulation Of The Kinase Activity Of Fibroblast Growth Factor Receptor And Uses Of Said Methods App 20150323548 - Graus Porta; Diana ; et al.	2015-11-12
Pyrazolopyrrolidine derivatives and their use in the treatment of disease Grant 8,975,417 - Bordas , et al. March 10, 2	2015-03-10
Pyrazolopyrrolidine compounds Grant 8,969,341 - Furet , et al. March 3, 2	2015-03-03
Organic compounds Grant 8,940,771 - Caravatti , et al. January 27, 2	2015-01-27
N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-urea App 20140378468 - Aichholz; Reiner ; et al.	2014-12-25
Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease App 20140349990 - BLANK; Jutta ; et al.	2014-11-27
Pyrazolopyrrolidine Compounds App 20140350010 - Furet; Pascal ; et al.	2014-11-27
Imidazopyrrolidinone Compounds App 20140343084 - FURET; Pascal ; et al.	2014-11-20
Cyclohexyl isoquinolinone compounds Grant 8,859,586 - Furet , et al. October 14, 2	2014-10-14
Cyclohexyl Isoquinolinone Compounds App 20140275158 - Furet; Pascal ; et al.	2014-09-18
Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors Grant 8,815,901 - Furet , et al. August 26, 2	2014-08-26
Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases Grant 8,815,926 - Furet , et al. August 26, 2	2014-08-26
Pyrrolidine-1,2-dicarboxamide Derivatives App 20140186469 - Fairhurst; Robin Alec ; et al.	2014-07-03
Pyrirnidinyl aryl urea derivatives being FGF inhibitors Grant 8,759,517 - Bold , et al. June 24, 2	2014-06-24
Pyrrolidine-1,2-dicarboxamide derivatives Grant 8,710,085 - Guagnano , et al. April 29, 2	2014-04-29
Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Grant 8,674,099 - Furet , et al. March 18, 2	2014-03-18
Imidazopyrrolidinone Compounds App 20140011798 - FURET; Pascal ; et al.	2014-01-09
Pyrrolidine-1,2-dicarboxamide Derivatives App 20140005232 - Fairhurst; Robin Alec ; et al.	2014-01-02
Quinoxaline Carboxamide Derivatives As Protein Tyrosine Kinase Inhibitors App 20130324519 - Furet; Pascal ; et al.	2013-12-05
Pyrrolopyrrolidinone Compounds App 20130317024 - Cotesta; Simona ; et al.	2013-11-28
Compounds and compositions as protein kinase inhibitors Grant 8,552,002 - Ding , et al. October 8, 2	2013-10-08
Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Grant 8,536,175 - Furet , et al. September 17, 2	2013-09-17
Pyrrolidine-1,2-dicarboxamide derivatives Grant 8,476,268 - Fairhurst , et al. July 2, 2	2013-07-02
Pyrimidinyl Aryl Urea Derivatives being FGF Inhibitors App 20130030171 - Bold; Guido ; et al.	2013-01-31
Compounds And Compositions As Protein Kinase Inhibitors App 20130012476 - DING; Qiang ; et al.	2013-01-10
Compounds And Compositions As Protein Kinase Inhibitors App 20130012704 - DING; Qiang ; et al.	2013-01-10
Method Of Identification Of Cells That Show Sensitivity To Modulation Of Signaling Mediated By A Fibroblast Growth Factor Receptor Or A Variant Thereof App 20120315648 - Graus Porta; Diana ; et al.	2012-12-13
Quinoxaline Carboxamide Derivatives As Protein Tyrosine Kinase Inhibitors App 20120309766 - FURET; Pascal ; et al.	2012-12-06
Quinoxaline Carboxamide Derivatives As Protein Tyrosine Kinase Inhibitors App 20120309741 - FURET; Pascal ; et al.	2012-12-06
Pyrimidinyl aryl urea derivatives being FGF inhibitors Grant 8,293,746 - Bold , et al. October 23, 2	2012-10-23
Pyrrolidine-1,2-dicarboxamide Derivatives App 20120263712 - FAIRHURST; Robin Alec ; et al.	2012-10-18
Method For Treating Haematological Cancers App 20120258940 - Caponigro; Giordano ; et al.	2012-10-11
Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors Grant 8,273,882 - Furet , et al. September 25, 2	2012-09-25
N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) -1--1-methyl-urea App 20120220600 - Aichholz; Reiner ; et al.	2012-08-30
Pyrrolidine-1,2-dicarboxamide derivatives Grant 8,227,462 - Fairhurst , et al. July 24, 2	2012-07-24
Phenylacetamides Suitable As Protein Kinase Inhibitors App 20120184561 - BOLD; Guido ; et al.	2012-07-19
Ether Derivatives Of Bicyclic Heteroaryls App 20120165310 - Chen; Bei ; et al.	2012-06-28
Phenylacetamides suitable as protein kinase inhibitors Grant 8,030,311 - Bold , et al. October 4, 2	2011-10-04
Phenylacetamides being FLT3 inhibitors Grant 7,977,338 - Furet , et al. July 12, 2	2011-07-12
Methods Of Monitoring The Modulation Of The Kinase Activity Of Fibroblast Growth Factor Receptor And Uses Of Said Method App 20110045511 - Graus Porta; Diana ; et al.	2011-02-24
Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors Grant 7,795,288 - Bold , et al. September 14, 2	2010-09-14
Method Of Treating Disorders Mediated By The Fibroblast Growth Factor Receptor App 20100120773 - Guagnano; Vito ; et al.	2010-05-13
Quinoxaline- and Quinoline-Carboxamide Derivatives App 20100105667 - FURET; Pascal ; et al.	2010-04-29
Organic Compounds App 20100105711 - Fairhurst; Robin Alec ; et al.	2010-04-29
Phenylacetamides being FLT3 Inhibitors App 20100075980 - Furet; Pascal ; et al.	2010-03-25
Method Of Identification Of Cells That Show Sensitivity To Modulation Of Signalingh Mediated By Fibroblast Growth Factor Receptor Or A Variant Thereof App 20100075337 - Graus Porta; Diana ; et al.	2010-03-25
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases Grant 7,652,022 - Floersheimer , et al. January 26, 2	2010-01-26
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,638,523 - Molteni , et al. December 29, 2	2009-12-29
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20090264649 - Molteni; Valentina ; et al.	2009-10-22
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,592,349 - Molteni , et al. September 22, 2	2009-09-22
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,563,894 - Molteni , et al. July 21, 2	2009-07-21
Organic Compounds App 20090163469 - Caravatti; Giorgio ; et al.	2009-06-25
Compounds and Compositions as Protein Kinase Inhibitors App 20090137804 - Ding; Qiang ; et al.	2009-05-28
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,514,447 - Molteni , et al. April 7, 2	2009-04-07
Method of Treating Disorders Mediated by the Fibroblast Growth Factor Receptor App 20090062320 - Guagnano; Vito ; et al.	2009-03-05
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20090012094 - Molteni; Valentina ; et al.	2009-01-08
Phenylacetamides Suitable as Protein Kinase Inhibitors App 20080319005 - Bold; Guido ; et al.	2008-12-25
Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent Diseases App 20080312192 - Bold; Guido ; et al.	2008-12-18
Pyrimidinyl Aryl Urea Derivatives Being Fgf Inhibitors App 20080312248 - Bold; Guido ; et al.	2008-12-18
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20080167308 - Molteni; Valentina ; et al.	2008-07-10
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20080139597 - Molteni; Valentina ; et al.	2008-06-12
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20080139559 - Molteni; Valentina ; et al.	2008-06-12
Thiazole and pyrazole derivatives as flt-3 kinase inhibitors App 20070167449 - Bold; Guido ; et al.	2007-07-19
Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors App 20070149538 - Molteni; Valentina ; et al.	2007-06-28
2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}-alkylbo- ronic acid derivatives App 20050239716 - Furet, Pascal ; et al.	2005-10-27
2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives Grant 6,933,290 - Furet , et al. August 23, 2	2005-08-23
2-{[n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylbor- onic acid derivatives App 20040167337 - Furet, Pascal ; et al.	2004-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.